Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix.
暂无分享,去创建一个
G. Matlashewski | A. Koushik | L. Villa | F. Coutlée | E. Franco | M. Roger | P. Tellier | Simon Gagnon | Soraya Khouadri | H. Richardson | Silvaneide Ferreira | João Simao | Harriet Richardson
[1] H. Bernard,et al. Genome variation of human papillomavirus types: Phylogenetic and medical implications , 2006, International journal of cancer.
[2] F. X. Bosch,et al. Worldwide Genomic Diversity of the High-Risk Human Papillomavirus Types 31, 35, 52, and 58, Four Close Relatives of Human Papillomavirus Type 16 , 2005, Journal of Virology.
[3] E. Franco,et al. Different P105 promoter activities among natural variants of human papillomavirus type 18. , 2005, The Journal of infectious diseases.
[4] C. Tremblay,et al. Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV‐seropositive and HIV‐seronegative women at risk for HIV infection , 2005, Journal of medical virology.
[5] G. Matlashewski,et al. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. , 2005, Cancer detection and prevention.
[6] C. Tremblay,et al. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. , 2004, The Journal of infectious diseases.
[7] C. Tremblay,et al. Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women. , 2004, The Journal of infectious diseases.
[8] Claude Fauquet,et al. Classification of papillomaviruses. , 2004, Virology.
[9] H. Bernard,et al. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. , 2004, Virology.
[10] C. Tremblay,et al. Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women. , 2003, The Journal of infectious diseases.
[11] S. Franceschi,et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis , 2003, British Journal of Cancer.
[12] M. Plummer,et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.
[13] C. Wheeler,et al. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. , 2003, American journal of obstetrics and gynecology.
[14] A. Hildesheim,et al. Host and viral genetics and risk of cervical cancer: a review. , 2002, Virus research.
[15] P. Chan,et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. , 2002, The Journal of infectious diseases.
[16] P. Chan,et al. Association of human papillomavirus type 58 variant with the risk of cervical cancer. , 2002, Journal of the National Cancer Institute.
[17] B. Rose,et al. Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia , 2002, International journal of cancer.
[18] E. Franco,et al. Persistent human papillomavirus infection and cervical neoplasia. , 2002, The Lancet. Oncology.
[19] T. Rohan,et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. , 2001, JAMA.
[20] Y. Taketani,et al. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. , 2001, Cancer letters.
[21] B. Rose,et al. Variable Oncogene Promoter Activity of Human Papillomavirus Type 16 Cervical Cancer Isolates from Australia , 2001, Journal of Clinical Microbiology.
[22] A. Giannoudis,et al. Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix , 2001, British Journal of Cancer.
[23] A. Giannoudis,et al. Human papillomavirus variants and squamous neoplasia of the cervix , 2001, The Journal of pathology.
[24] K. Buetow,et al. Human papillomavirus type 16 variants and risk of cervical cancer. , 2001, Journal of the National Cancer Institute.
[25] T. Rohan,et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. , 2000, The Journal of general virology.
[26] F. Coutlée,et al. Detection of Human Papillomavirus Type 16 DNA in Consecutive Genital Samples Does Not Always Represent Persistent Infection as Determined by Molecular Variant Analysis , 2000, Journal of Clinical Microbiology.
[27] C. Wheeler,et al. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. , 2000, The Journal of general virology.
[28] David R. Scott,et al. Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.
[29] I. Nindl,et al. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra‐epithelial neoplasia and cervical cancer , 1999, International journal of cancer.
[30] L. Gergely,et al. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. , 1999, The Journal of general virology.
[31] G. Voglino,et al. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms , 1998, The Lancet.
[32] E. Wilander,et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. , 1998, Cancer research.
[33] K. Holmes,et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. , 1997, Journal of the National Cancer Institute.
[34] C. Wheeler,et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective , 1997, Journal of virology.
[35] C. Desaintes,et al. Control of papillomavirus DNA replication and transcription. , 1996, Seminars in cancer biology.
[36] C. Wheeler,et al. Intratype variation in 12 human papillomavirus types: a worldwide perspective , 1996, Journal of virology.
[37] Xu-Gang Luo,et al. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] N. Kiviat,et al. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world , 1995, Journal of clinical microbiology.
[39] F. Stubenrauch,et al. Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancers , 1994, International journal of cancer.
[40] H. Pfister,et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups , 1993, Journal of virology.
[41] N. Kiviat,et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations , 1993, Journal of virology.
[42] B. Drescher,et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind , 1992, Journal of virology.
[43] T. Nagase,et al. Binding of the c-myb proto-oncogene product to the simian virus 40 enhancer stimulates transcription. , 1990, The Journal of biological chemistry.
[44] S. Cole,et al. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer , 1986, Journal of virology.